A single-center, dose-comparison, pilot study of botulinum neurotoxin type A in female patients with upper facial rhytids: Safety and efficacy

Dose Comparison

A single-center, dose-comparison, pilot study of botulinum neurotoxin type A in female patients with upper facial rhytids: Safety and efficacy

Yearbook of Plastic and Aesthetic Surgery ◽

10.1016/s1535-1513(09)79405-6 ◽

2011 ◽

Vol 2011 ◽

pp. 132-134

Author(s):

S.H. Miller

Keyword(s):

Pilot Study ◽

Botulinum Neurotoxin ◽

Type A ◽

Single Center ◽

Safety And Efficacy ◽

Female Patients ◽

Dose Comparison

A Phase I/II Randomized, Double Blind, Active-controlled, Single Center Clinical Trial for Evaluation of Safety and Efficacy of ATGC-110, An Intramuscularly Administered Clostridium Botulinum Neurotoxin Type A, in Adult Patients With Moderate to Severe Glabellar Frown Lines

Case Medical Research ◽

10.31525/ct1-nct04281095 ◽

2020 ◽

Author(s):

Keyword(s):

Clinical Trial ◽

Phase I ◽

Clostridium Botulinum ◽

Botulinum Neurotoxin ◽

Type A ◽

Adult Patients ◽

Single Center ◽

Double Blind ◽

Safety And Efficacy ◽

A single-center, dose-comparison, pilot study of the safety and efficacy of botulinum toxin type a in female subjects with upper facial rhytids

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2004.10.343 ◽

2005 ◽

Vol 52 (3) ◽

pp. P84

Keyword(s):

Botulinum Toxin ◽

Pilot Study ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Single Center ◽

Safety And Efficacy ◽

Dose Comparison ◽

Female Subjects

Dose-dependent, central effects of botulinum neurotoxin type A: A pilot study in the alert behaving cat

Neurology ◽

10.1212/wnl.48.2.456 ◽

1997 ◽

Vol 48 (2) ◽

pp. 456-464 ◽

Cited By ~ 31

Author(s):

B. Moreno-Lopez ◽

A. M. Pastor ◽

R. R. de la Cruz ◽

J. M. Delgado-Garcia

Keyword(s):

Pilot Study ◽

Botulinum Neurotoxin ◽

Type A ◽

Central Effects ◽

Dose Dependent

Treating hand tremor in Parkinson disease with botulinum neurotoxin type A: A pilot study

Toxicon ◽

10.1016/j.toxicon.2012.07.159 ◽

2013 ◽

Vol 68 ◽

pp. 118-119

Author(s):

F. Rahimi ◽

D. Debicki ◽

C. Bee ◽

A. South ◽

M. Jog

Keyword(s):

Pilot Study ◽

Parkinson Disease ◽

Botulinum Neurotoxin ◽

Type A ◽

Hand Tremor ◽

A Pilot Study to Investigate the Combined Use of Botulinum Neurotoxin Type A and Functional Electrical Stimulation, with Physiotherapy, in the Treatment of Spastic Dropped Foot in Subacute Stroke

Artificial Organs ◽

10.1046/j.1525-1594.2002.06948.x ◽

2002 ◽

Vol 26 (3) ◽

pp. 263-266 ◽

Cited By ~ 15

Author(s):

Catherine A. Johnson ◽

Duncan E. Wood ◽

Ian D. Swain ◽

Anthony M. Tromans ◽

Paul Strike ◽

...

Keyword(s):

Electrical Stimulation ◽

Pilot Study ◽

Functional Electrical Stimulation ◽

Botulinum Neurotoxin ◽

Type A ◽

Subacute Stroke ◽

Combined Use

Faculty Opinions recommendation of In the human urothelium and suburothelium, intradetrusor botulinum neurotoxin type A does not induce apoptosis: preliminary results.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1718956.1228054 ◽

2010 ◽

Author(s):

JLH Ruud Bosch

Keyword(s):

Botulinum Neurotoxin ◽

Type A ◽

Preliminary Results ◽

Faculty Opinions recommendation of Botulinum neurotoxin type A is internalized and translocated from small synaptic vesicles at the neuromuscular junction.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717988167.793477443 ◽

2013 ◽

Author(s):

Patrick McNutt ◽

Ian Gut

Keyword(s):

Neuromuscular Junction ◽

Synaptic Vesicles ◽

Botulinum Neurotoxin ◽

Type A ◽

OnabotulinumtoxinA exhibits greater efficacy compared to purified botulinum neurotoxin type A (BoNT/A-150 kDa) in peripheral pain models

Toxicon ◽

10.1016/j.toxicon.2020.11.490 ◽

2021 ◽

Vol 190 ◽

pp. S70

Author(s):

Sudhakar R. Subramaniam ◽

Greg Nicholson ◽

Brian B. Cai ◽

Amy D. Brideau-Andersen ◽

Ron S. Broide

Keyword(s):

Botulinum Neurotoxin ◽

Type A ◽

Pain Models ◽

Peripheral Pain

Not only gustatory sweating and flushing: Signs and symptoms associated with Frey's syndrome and the role of botulinum neurotoxin type A therapy

Toxicon ◽

10.1016/j.toxicon.2020.11.437 ◽

2021 ◽

Vol 190 ◽

pp. S46-S47

Author(s):

Maria Raffaella Marchese ◽

Giovanni Almadori

Keyword(s):

Botulinum Neurotoxin ◽

Signs And Symptoms ◽

Type A ◽

Frey’S Syndrome ◽

Gustatory Sweating ◽

Frey's Syndrome